Zhijian Ma

3PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 23, 2026
Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy.

|Sep 23, 2024
Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma.

Wengui Shi, Lianshun Li, Huiming Zhao

|Dec 28, 2023
Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.

Zhijian Ma, Qianlin Gu, Yiwei Dai

Pageof 1

Frequent Collaborators

2 joint publications

Wengui Shi

2 joint publications

Huiming Zhao

2 joint publications

Qianlin Gu

2 joint publications

Yuman Dong